These findings were not confirmed by Schmidt et al., who investigated via IHC 275 resected NSCLC patients, reporting a great amount of PSMA expression in the endothelium of the tumor vessels (49% of cases) but a lower fraction in tumor cells (6%), mainly in the squamous cancer subtype (82%). This evidence concerns the gene FOLH1 and neoplasm.